Andrew McLaughlin

Andrew McLaughlin is a seasoned professional in business intelligence and data analytics with over two decades of experience in the pharmaceutical and technology sectors. Currently serving as the Global Business Intelligence Lead at Alnylam Pharmaceuticals, Andrew has held multiple leadership roles, focusing on actionable metrics and stakeholder-driven reporting. Prior to this, Andrew was a Senior Data Operations Manager at Biogen, where responsibilities included setting up a team of Data Stewards across Europe and Canada and receiving recognition for contributions to EFPIA disclosure reporting. Experience also includes roles at Auto Trader UK overseeing financial systems and at HP CDS providing finance systems support across EMEA. Andrew holds a Professional Certificate in Business Management from The Open University and a degree in Mechanical Engineering from the University of Hertfordshire.